Determination of GHB (liquid Ecstasy) in human samples was a challenge until today. Expensive and laborious chromatographic methods did not allow the prompt determination of suspicious samples. The BÜHLMANN GHB enzymatic assay will give the toxicology laboratories a quick, easy and cost efficient screening tool to investigate even samples with lower suspicion.

The GHB enzymatic assay is available now as a CE marked in vitro diagnostics. Evaluated and CE marked protocols for the most important clinical chemistry analyser will be available soon.